Table 3.

Adverse symptomatic outcome (greater than median symptom severity in days 2–4, or greater than median duration of symptoms) according to duration of antibiotic prescribed and antibiotic class

Poor symptomatic outcome, n (%)Univariate risk ratio (95% CI, P-value)Risk ratio controlling for baseline severity, antibiotic type (immediate or delayed), and clustering (95% CI, P-value)aRisk ratio controlling for propensity score (95% CI, P-value)Risk ratio controlling for propensity score in imputed dataset (95% CI, P-value)
Duration of antibiotic prescription
5 days (reference category)105/185 (56.8)1.001.001.00
7 days312/535 (58.3)1.03 (0.89 to 1.19)
P= 0.713
1.03 (0.89 to 1.20)
P= 0.685
1.06 (0.91 to 1.23)
P= 0.443
1.06 (0.91 to 1.23)
P= 0.462
10 days108/168 (64.3)1.13 (0.96 to 1.34)
P= 0.148
1.13 (0.95 to 1.35)
P= 0.162
1.22 (1.02 to 1.46)
P= 0.026
1.22 (1.02 to 1.46)
P= 0.026
Antibiotic class
Phenoxymethylpenicillin (reference category)419/714 (58.7)1.001.001.001.00
Other antibiotics125/206 (60.7)1.03 (0.91 to 1.17)
P= 0.603
1.04 (0.91 to 1.18)
P= 0.547
0.98 (0.84 to 1.12)
P= 0.807
0.94 (0.68 to 1.32)
P= 0.733
  • a For duration, the model also controls for whether the antibiotics prescribed were immediate or delayed.